Daiichi Sankyo – sales performance, data and rankings – Top Pharma List

Posted On Sep 17 2016 by

#sankyo pharma # Daiichi Sankyo Data by GlobalData GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value. To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com Featured jobs Principal Medical Writer Great salary and benefits ID Search Selection Director, Scientific Services 80 – 100,000 or more according to skills and experience + …


Herb Pharm Pharma Kava

Posted On Sep 17 2016 by

#pharma kava #Herb Pharm Pharma Kava 1 fl oz (29.6 ml) Liquid Herbal Extract Piper Methysticum Rhizome Root Promotes Peaceful Relaxation* Reduces Stress Frustration* Pharma Kava is prepared from the rhizome roots of Piper methysticum plants which are naturally grown in the South Pacific islands of Vanuatu. *This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. FDA advises that a potential risk of rare, but severe, liver injury may be associated with kava. Ask a healthcare professional before use if you have, or have …


UCB to buy Schwarz Pharma for $5

Posted On Sep 17 2016 by

#schwarz pharma # UCB to buy Schwarz Pharma for $5.6 billion LONDON (MarketWatch) — Belgium’s UCB on Monday said it agreed to pay $5.6 billion for Germany’s Schwarz Pharma, the third multibillion-dollar takeover in the European pharmaceutical industry in the past five days. UCB (000373953) said it’s paying 4.4 billion euros in cash and shares, representing a 20% premium to Friday’s close, for Schwarz Pharma (722190). The deal follows proposals by Germany’s Merck KGaA (659990) to buy Switzerland’s Serono SRA, +0.00% for $13.3 billion, and Denmark’s Nycomed to buy the pharmaceutical operations of Germany’s Altana AAA, +8.70% for $5.8 billion. …


Herb Pharm Pharma Kava 1 oz

Posted On Sep 17 2016 by

#pharma kava # Details Promotes Peaceful Relaxation. Reduces Stress Frustration. 40-drop dose contains 64 mg of kavalactones. Pharma Kava is prepared from the rhizome roots of Piper methysticum plants which are naturally grown in the South Pacific islands of Vanuatu. Caution: US FDA advises that a potential risk of rare but severe liver injury may be associated with kava-containing dietary supplements. Ask a healthcare professional before use if you have or have had liver problems frequently use alcoholic beverages or are taking any medication. Stop use and see a doctor if you develop symptoms that may signal liver problems including …


Sankyo pharma

Posted On Sep 17 2016 by

#sankyo pharma # Headquarters Daiichi Sankyo Co. Ltd 3-5-1, Nihonbashi Honcho, Chuo-ku, Tokyo 103-8426 Japan


SPI Pharma – Streamlining ODT technology – World Pharmaceutical Frontiers

Posted On Sep 17 2016 by

#spi pharma # SPI Pharma – Streamlining ODT technology Developing orally disintegrating tablets can be expensive due to their complex dosage forms. Two platforms are available that aim to improve the manufacturing process. An orally disintegrating tablet (ODT) is a tablet that when placed in the mouth, usually on the tongue, disintegrates without the aid of water in less than 60 seconds. SPI Pharma offers two distinct platforms to facilitate the formulation of ODTs – Pharmaburst and Pharmafreeze. In addition, SPI Pharma provides a taste-masking encapsulation technology to work in conjunction with these two platforms, Pharmacaps, which masks the bitter …


The 5-Minute Guide to Horizon Pharma PLC Stock – The Motley Fool

Posted On Sep 17 2016 by

#horizon pharma # The 5-Minute Guide to Horizon Pharma PLC Stock Value investors don’t need to know a mitochondria from a hole in the ground to sense something’s amiss with Horizon Pharmaceuticals (NASDAQ:HZNP ) stock. Over the past several years the company’s sales have exploded, yet the stock fallen roughly 50% from its peak last summer. With a forward price-to-earnings ratio under 10, this looks like a bargain hunter’s dream come true. Before you go diving in, take five minutes to familiarize yourself with this company. You’ll be glad you did. Pharma-funds Even if you don’t follow pharmaceutical industry news, …


Pharma, Biotech and Medical-Device Sales Careers

Posted On Sep 17 2016 by

#biotech pharma jobs # Pharma, Biotech, Medical-Device Sales: Which Is for You? Pharma, Biotech and Medical-Device Sales Careers Salespeople s roles in the pharmaceutical, biotechnology and medical-device industries are closely related, but there are some key differences in what each of the three types of sales jobs entails, as well as in the skills and personalities necessary to succeed. From differing levels of technical know-how to varying degrees of on-the-job autonomy, here s what to keep in mind before targeting one of the areas as a prospective salesperson. Breaking into the Field Although it is tough to get a sales …


Sun Pharma inks pact to buy DUSA for $230 million – The Hindu

Posted On Sep 17 2016 by

#dusa pharma # Sun Pharma inks pact to buy DUSA for $230 million Sun Pharmaceutical Industries, on Thursday, said it had inked a pact to acquire U.S.-based DUSA Pharmaceuticals for around $230 million (about Rs.1,250 crore). Sun Pharma and DUSA Pharmaceuticals have entered into a definitive agreement under which Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan photo-dynamic therapy platform, Sun Pharma said in a statement. Under the terms of the agreement, a 100 per cent subsidiary of Sun Pharma will commence a tender offer for all of the outstanding common stock of …


Horizon Pharma Raises CEO Walbert – s Pay 10-Fold to $93

Posted On Sep 16 2016 by

#horizon pharma # Horizon Pharma Raises CEO Walbert’s Pay 10-Fold to $93.4 Million Horizon Pharma Plc gave Chief Executive Officer Timothy Walbert a $93.4 million pay package for 2015, a 10-fold increase from the previous year as the company came under scrutiny for its distribution practices. Walbert received stock options valued at $47.4 million and $43.5 million in restricted shares, according to a preliminary proxy filed Tuesday. The options and about a quarter of the shares will vest over four years, with the remaining stock vesting in 2018 if the firm meets performance targets. His pay package for 2014 was …